Navigation Links
3SBio Inc. Announces Unaudited Second Quarter 2009 Results
Date:8/11/2009

Gross profit 137,806 20,176 Operating expenses Research and development costs (6,464) (946) Sales, marketing and distribution expenses (68,889) (10,086) General and administrative expenses (14,763) (2,161) Total operating expenses (90,116) (13,193) Operating income 47,690 6,983 Other income /(expenses), net Interest income 6,526 955 Grant income 187 27 Disposal gain on available- for-sale securities -- -- Impairment loss on available-for-sale securities -- -- Others 1,339 196 Total other income, net 8,052 1,178 Income before income tax expense 55,742 8,161 Income tax expense (8,088) (1,184) Net income 47,654, 6,977 Net income per share: Basic and diluted 0.32 0.05 Basic weighted average number of shares outstanding 150,586,455 150,586,455 Effect of dilutive potential shares 107,818 107,818 Diluted weighted average number of shares outstanding 150,694,273 150,694,273 Net income per ADS: Basic and diluted 2.21 0.32 Basic weighted average number of ADSs outstanding 21,512,351 21,512,351 Effect of dilutive potential ADSs 15,402 15,402 Diluted weighted average number of ADSs outstanding 21,527,753 21,527,753

Notes to reconciliation of our GAAP statements of
'/>"/>

SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. 3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009
2. 3SBio Inc. Announces Unaudited First Quarter 2009 Results
3. 3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP
4. 3SBio Inc. Announces Filing of Annual Report on Form 20-F
5. 3SBio Inc. to Present at The CIBC World Markets 18th Annual Healthcare Conference
6. Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results
7. Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors
8. Epix Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS Phase 2 Will be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
9. Leading Medical Developer Announces Plans for Texoma Medical Plaza
10. iMedX Announces Investment of $13M From RFE Investment Partners
11. Health Market Science Announces Commercial Release of CompleteSpend V2.5

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...d, Nov. 30 Tyco Internat... 2010 annual general meeting of shareholders will ...Central European time at the Park Hyatt Zurich Hot.... Registered shareholders as of January 11, 2010 (...nnual general meeting. Additionally, individuals ...
(Date:11/30/2009)...ent and extensive discussion in the scientific com...n Health Care (IQWiG) presents its methods for eva... Institute can now apply these methods when workin...int Committee (G-BA). The method developed by IQWi...e GKV-Spitzenverband [National Association of Heal...
(Date:11/30/2009)... Reportlinker.com announces that a ...alogue: ,, Key Players and Innovative Start-Up...ients, pharma, food and drinks ,, http://www....ve-Start-Ups-in-Nutraceuticals-Emerging-strategies... Nutraceuticals are bioactive compounds with prope...
(Date:11/30/2009)... 30 American Diversified...ed to announce the appointment of Howard M. McEld... Board of Directors. Mr. McEldowney, whose investm... the Chemical Bank in New York City and subsequent...ldowney, San Francisco, an institutional money man...
(Date:11/30/2009)...ogy (EAU) and Europa Uomo, the European,advocacy ...ve entered into an,affiliated partnership as part...rove,patient awareness in Europe with regards to ...amsson, Secretary-General of the EAU: "Thanks to t...o will gain access to the latest information on,o...
Breaking Medicine News(10 mins):Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2
... Israel, May 5 Lumenis Ltd. announced plans to,al...nis Vision) for,aggressive growth while at the sam...nd reliability., Lumenis, Ophthalmic Unit has bee...nt for Business Development, and,will replace Mr. ...
...ULU, MAY 5, 2008 Two scientists who helped explai...nd other organs have been chosen to receive the 20... , Philip A. Beachy, PhD, and Clifford J. Tabin,...gnals guide the formation of the brain, limbs, spi...
...L HILL Parents of children with autism were rough... mental disorder, such as schizophrenia, than pare... Swedish birth and hospital records by a Universit...sm spectrum disorders in the offspring, appears in...
...China, May 4 /Xinhua-PRNewswire-FirstCall/ -- Chin...r "the Company") (OTC Bulletin,Board: CSKI), a lea...xternal use, over-the-counter drugs in the People,...Harbin First Bio-Engineering Company Limited ("Fir...
...e sequence linked to an expanding waist line, weig...has been discovered as part of a study published t... also shows that the gene sequence is significantl...ways of treating obesity. , Scientists from Imper...
...c Society Elects Top Officers at 2008 Annual Meeti...astic surgeon,Alan H. Gold, MD, is the new Preside...urgery (ASAPS). The Aesthetic Society, with nearly...ection of new officers was held on May 4, during t...
Other Medicine News:Health News:Lumenis Announces changes in Lumenis Vision Strategic Business Unit 2Health News:March of Dimes awards $250,000 prize to leaders in understanding embryonic development 2Health News:Mental disorders in parents linked to autism in children 2Health News:China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits 2Health News:China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits 3Health News:Gene sequence that can make half of us fatter is discovered 2Health News:Long Island Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 2Health News:Long Island Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 3
(Date:11/30/2009)... N.J., Nov. 30 MedQu...echnology-enabled clinical documentation services,...ological Society of North America (RSNA) conferenc... the product leverages SpeechQ(TM), the company,s ...on used by thousands of radiologists. MedQuist ha...
(Date:11/30/2009)...alif., Nov. 30 StemCyte, Inc. conc...greement with Academia Sinica, the National Labora...d Intellectual Property (IP) related to the treatm...d and IP was pioneered by a team led by Professor ... Professor Lin is currently the exclusive collabor...
(Date:11/30/2009)...YORK, Nov. 30 Reportlinker.com ann...ble in its catalogue: ,, Diabetes Diagnostics ...eportlinker.com/p0164347/Diabetes-Diagnostics---A-...agnosis market is driven by a steady increase in t...in the developed and developing parts of the world...
Breaking Medicine Technology:MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 61111 1Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 61111 2realbuzz com Top Tips to Cut the Calories This Christmas Party Season 61108 1realbuzz com Top Tips to Cut the Calories This Christmas Party Season 61108 2Worksite wellness programs may reduce employee absenteeism 61107 1Worksite wellness programs may reduce employee absenteeism 61107 2
... ROCK, Ark., Oct. 8 A research study,at the Unive...esigned to,establish one of the largest and most r...dy of breast cancer occurrence. Spit for the Cure...ousands of women and is being conducted with the s...or the Cure. The saliva samples will be used to,cr...
...A, Oct. 8 Alimera Sciences Inc., a privately held...mited (Nasdaq: PSDV; ASX:,PSD; Xetra: PSI), announ...(TM) (Fluocinolone Acetonide in Diabetic Macular E... Diabetic Macular Edema. FAME is a,double masked, ...ver 900,patients in the U.S., Canada, Europe and I...
Other Medicine Technology:Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research 2Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema 2Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema 3Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema 4
...System is a long term, quality solution based on a...rior stabilized and anatomically correct cruciate ...rovides the flexibility needed to address patients...nd ease of identification keeps the user in mind a...
...l Iso-C3D C-Arm imaging system interface sets a ne...Combining mobility and accurate imaging with Medtr...technologies deliver the most complete perspective...e new standard in the OR. Medtronic-SNT has taken...
OmniSight image guided surgery system with Calyx 2 Fluoroscopic Tracking Module
...ents are the next evolution in transforaminal lumb...e and functionally sound instruments.. The T.L.I.F...moval and disc preparation instruments designed to... Excellent design, a wide range of instrument opti...
Medicine Products: